MKS Inc. shares have declined 14.3% since the most recent earnings report. Post-earnings stock drop reflects negative investor reaction to financial results with moderate ongoing effects on valuation and sentiment.
| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | 1 | — | 1 | — | 10 | 3 | — | 10 | 5 | — | 2 | 1 |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 1.00 |
—
—
—
|
| 2025 | 0.88 |
—
—
—
—
|
| 2024 | 0.88 |
—
—
—
—
|
| 2023 | 0.88 |
—
—
—
—
|
| 2022 | 0.88 |
—
—
—
—
|
| 2021 | 0.86 |
—
—
—
—
|
| 2020 | 0.80 |
—
—
—
—
|
| 2019 | 0.80 |
—
—
—
—
|
| 2018 | 0.78 |
—
—
—
—
|
| 2017 | 0.71 |
—
—
—
—
|
| 2016 | 0.68 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 875.00 | 714.00 | 675.00 | 611.00 |
| Receivables | 603.00 | 615.00 | 651.00 | 830.00 |
| Inventory | 991.00 | 893.00 | 921.00 | 1,033.00 |
| Other | 227.00 | 252.00 | 263.00 | 300.00 |
| 2,696.00 | 2,474.00 | 2,510.00 | 2,774.00 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 327.00 | 341.00 | 407.00 | 534.00 |
| ST’ Debt | 93.00 | 50.00 | 51.00 | 1,399.00 |
| Other | 428.00 | 384.00 | 469.00 | 491.00 |
| 848.00 | 775.00 | 927.00 | 2,424.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1,078.00 | 1,248.00 | — | — |
—
|
| ’25 | 936.00 | 973.00 | 988.00 | 1,034.00 |
3,931.00
|
| ’24 | 868.00 | 887.00 | 896.00 | 935.00 |
3,586.00
|
| ’23 | 794.00 | 1,003.00 | 932.00 | 893.00 |
3,622.00
|
| ’22 | 742.00 | 765.00 | 954.00 | 1,086.00 |
3,547.00
|
| ’21 | 694.00 | 750.00 | 742.00 | 764.00 |
2,950.00
|
| ’20 | 535.70 | 544.30 | 589.80 | 660.20 |
2,330.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 53.00 | 243.00 | — | — |
—
|
| ’25 | 141.00 | 165.00 | 197.00 | 142.00 |
645.00
|
| ’24 | 67.00 | 122.00 | 163.00 | 176.00 |
528.00
|
| ’23 | 37.00 | (59.00) | 160.00 | 181.00 |
319.00
|
| ’22 | 41.00 | 105.00 | 199.00 | 184.00 |
529.00
|
| ’21 | 127.00 | 165.00 | 153.00 | 195.00 |
640.00
|
| ’20 | 74.90 | 139.00 | 152.10 | 147.00 |
513.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 28.00 | 189.00 | — | — |
—
|
| ’25 | 123.00 | 136.00 | 146.00 | 95.00 |
500.00
|
| ’24 | 49.00 | 95.00 | 141.00 | 126.00 |
411.00
|
| ’23 | 20.00 | (77.00) | 142.00 | 150.00 |
235.00
|
| ’22 | 29.00 | 34.00 | 173.00 | 129.00 |
365.00
|
| ’21 | 100.00 | 149.00 | 133.00 | 171.00 |
553.00
|
| ’20 | 64.90 | 118.10 | 123.10 | 121.90 |
428.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1.18 | 2.41 | — | — |
—
|
| ’25 | 0.77 | 0.92 | 1.10 | 1.58 |
4.37
|
| ’24 | 0.22 | 0.33 | 0.92 | 1.33 |
2.81
|
| ’23 | (0.64) | (26.47) | 0.58 | (1.02) |
(27.54)
|
| ’22 | 2.57 | 2.32 | 0.09 | 0.81 |
5.56
|
| ’21 | 2.20 | 2.63 | 2.38 | 2.69 |
9.90
|
| ’20 | 1.25 | 1.33 | 1.66 | 2.08 |
6.33
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 64.77 | 63.44 | 95.71 | 54.84 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 181.03 | 114.15 | 147.40 | 170.37 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10,900 | 10,200 | 10,200 | 10,300 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.33 | 0.36 | 0.35 | 0.38 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,547.00 | 3,622.00 | 3,586.00 | 3,931.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 43.61% | 45.33% | 47.63% | 46.73% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 433.00 | (1,928.00) | 180.00 | 304.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.21% | (53.23%) | 5.02% | 7.73% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 333.00 | (1,841.00) | 190.00 | 295.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 324.00 | 430.00 | 378.00 | 370.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 59.41 | 54.22 | 53.28 | 58.41 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 5.57 | (27.54) | 2.82 | 4.39 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.86 | 4.78 | 7.85 | 9.58 | ‡‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.75) | (1.26) | (1.74) | (2.15) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.11 | 3.52 | 6.11 | 7.43 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 75.09 | 37.01 | 34.50 | 40.40 | ‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 59.70 | 66.80 | 67.30 | 67.30 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.57 | 0.00 | 37.02 | 36.40 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.43 | 1.84 | 1.96 | 2.74 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.13 | 2.70 | 3.03 | 3.96 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.56 | 2.92 | 3.03 | 3.63 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 24.85 | 45.02 | 26.40 | 28.56 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 529.00 | 319.00 | 528.00 | 645.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (164.00) | (84.00) | (117.00) | (145.00) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 365.00 | 235.00 | 411.00 | 500.00 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,842.00 | 1,848.00 | 1,699.00 | 1,583.00 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,927.00 | 4,789.00 | 4,538.00 | 4,201.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,017.00 | 3,914.00 | 3,824.00 | 3,526.00 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,483.00 | 2,472.00 | 2,322.00 | 2,719.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.15% | (17.86%) | 2.15% | 3.39% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.54% | (15.21%) | 5.06% | 5.28% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 9.04% | (52.94%) | 7.93% | 11.70% | — | — | — |
ROE
|
MKS Instruments (MKSI) offers a compelling yet cautious story for investors eyeing the semiconductor boom. The company has delivered strong revenue growth, compounding at 13% annually from $1.3 billion in 2016 to $3.59 billion in 2024, fueled by vacuum tech, lasers, and the transformative $5.1 billion Atotech acquisition that expanded into chemicals and plating. However, this deal spiked debt to $4.54 billion, triggered a staggering $1.84 billion net loss in 2023 from impairments amid a chip downturn, and exposed cyclical vulnerabilities—despite a solid 2024 rebound with $190 million profits and improving margins.
Analysts project bright skies ahead: 9% annual revenue growth to $4.66 billion by 2027, EPS tripling from $2.82 to $7.63, and ROE recovering toward historical highs, banking on AI-driven semi capex and Atotech synergies. Free cash flow is positive at $410 million in 2024, supporting potential debt reduction, though leverage remains elevated at nearly 2x debt-to-equity.
Yet risks loom large for the risk-averse: persistent insider selling, premium valuations (37x PE, forward 60x), and sensitivity to industry slumps that could hammer margins and cash flow. With analyst targets ranging from 48% downside to 15% upside, MKSI rewards patient semi bulls but demands monitoring debt metrics and Q1 2026 guidance before diving in.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.